2[1]Vogel F,Droszez V,Vondra V,et al.Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.J Antimicrob Chemother,1997,40:863
3[2]Fine MJ,Medsger AR,Stone RA,et al.The hospital discharge decision for patients with community acquired pneumonia.Arch Intern Med,1997,157:47
4[3]Ramirez JA.Switch therapy with β-lactamase inhibitors in patients with community acquired pneumonia.Ann Pharmacother,1998,32:322
6[5]Paladino JA,Sperry HE,Bacter JM,et al.Clinical and economic evaluation of oral ciprofloxacin after abbreviated course of intravenous antibiotic.Am J Med,1991,91:462
7Cadisch R, Streit E, Haamann K. Exacerbation of pseudopartytic myasthenia gravis following azithromycin (Zithromax) [ J ]. Schweiz Med Wochenschr, 1996,126(8) :308 - 310.
8Wallace M R, Miller L K, Nguyen M T, et al. Ototoxicity with azithromycin[J]. Lancet, 1994,343(8891):241.
9Longo G, Valenti C, Gandini G, et al. Azithromycin-induced intrahepatic cholestasis[ J]. Am J Med, 1997,102(2) :217 - 218.
10Girard A E, Girard D, English A R, et al. Pharmacokinetic and in vivo studies with azithromycin( CP-62, 993), a new macrolide with an extend half-life and excellent tissue distribution [ J ]. Antmicrob Agents Chemother, 1987,31 : 1948 - 1954.
